SHEL.UK

2,493

+1.65%↑

BP

380.25

+2.2%↑

SHEL.UK

2,493

+1.65%↑

BP

380.25

+2.2%↑

SHEL.UK

2,493

+1.65%↑

BP

380.25

+2.2%↑

SHEL.UK

2,493

+1.65%↑

BP

380.25

+2.2%↑

SHEL.UK

2,493

+1.65%↑

BP

380.25

+2.2%↑

Search

Smith & Nephew PLC

Затворен

1,079 1.27

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

1059.5

Максимум

1082

Ключови измерители

By Trading Economics

Приходи

107M

Продажби

1.4B

P/E

Средно за сектора

30.871

23.767

EPS

0.376

Дивидентна доходност

2.68

Марж на печалбата

7.57

Служители

17,349

EBITDA

260M

Препоръки

By TipRanks

Препоръки

Купи

12-месечна прогноза

+15.17% upside

Дивиденти

By Dow Jones

Дивидентна доходност

Средно за сектора

2.68%

5.86%

Следващи печалби

5.08.2025 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

432M

9.5B

Предишно отваряне

1077.73

Предишно затваряне

1079

Smith & Nephew PLC Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

12.05.2025 г., 22:34 ч. UTC

Придобивния, сливания и поглъщания

Ampol to Sell Retail Electricity Businesses in Australia, New Zealand

12.05.2025 г., 23:48 ч. UTC

Пазарно говорене

Gold Edges Higher on Possible Technical Recovery -- Market Talk

12.05.2025 г., 23:46 ч. UTC

Пазарно говорене

Nikkei Likely to Rise on Hopes for Improving U.S.-China Trade Relations -- Market Talk

12.05.2025 г., 23:34 ч. UTC

Пазарно говорене

Trade Deal Lowers US Recession Risks to 35% -- Market Talk

12.05.2025 г., 23:21 ч. UTC

Пазарно говорене

US-China Trade Deal Still Risks Stagflation; Supply Chain Disruption -- Market Talk

12.05.2025 г., 22:54 ч. UTC

Пазарно говорене

Australian Treasurer Warns Uncertainty Will Still Dominate Markets -- Market Talk

12.05.2025 г., 22:43 ч. UTC

Печалби

Telefonica Brasil 1Q EPS BRL0.65 >VIV

12.05.2025 г., 22:14 ч. UTC

Топ новини

Drugmakers Spared Worst-Case Drug Pricing Scenario for Now -- 2nd Update

12.05.2025 г., 22:08 ч. UTC

Придобивния, сливания и поглъщания

Ampol Expects Replacement-Cost Ebitda Uplift by Run Rate at End-2025 of Around A$30 Million/Year

12.05.2025 г., 22:08 ч. UTC

Придобивния, сливания и поглъщания

Ampol Expects Pretax Proceeds of Around A$65 Million From Transactions

12.05.2025 г., 22:07 ч. UTC

Придобивния, сливания и поглъщания

Ampol to Sell Australia Retail Electricity Business for Nominal Sum

12.05.2025 г., 22:07 ч. UTC

Придобивния, сливания и поглъщания

Ampol to Sell Australia Retail Electricity Business to AGL

12.05.2025 г., 22:06 ч. UTC

Придобивния, сливания и поглъщания

Meridian to Take on Flick, Z Energy Branded Electricity Customers

12.05.2025 г., 22:06 ч. UTC

Придобивния, сливания и поглъщания

Meridian Energy to Buy Business From Ampol for NZ$70 Million

12.05.2025 г., 22:05 ч. UTC

Придобивния, сливания и поглъщания

Ampol to Sell New Zealand Electricity Retailing Businesses to Meridian Energy

12.05.2025 г., 22:04 ч. UTC

Придобивния, сливания и поглъщания

Ampol to Sell Retail Electricity Businesses in Australia, New Zealand

12.05.2025 г., 21:15 ч. UTC

Топ новини

Republican Tax Plan Boosts SALT Deduction, Ends Green-Energy Breaks -- 2nd update -- WSJ

12.05.2025 г., 21:01 ч. UTC

Печалби

Constellation Software 1Q Rev $2.65B >CSU.T

12.05.2025 г., 21:01 ч. UTC

Печалби

Constellation Software 1Q Net $115M >CSU.T

12.05.2025 г., 21:01 ч. UTC

Печалби

Constellation Software 1Q EPS $5.44 >CSU.T

12.05.2025 г., 20:50 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk

12.05.2025 г., 20:50 ч. UTC

Пазарно говорене
Печалби

Basic Materials Roundup: Market Talk

12.05.2025 г., 20:44 ч. UTC

Топ новини

Trade Thaw Sparks Stock Rally, Leaves Wall Street Cautious -- WSJ

12.05.2025 г., 20:31 ч. UTC

Топ новини

How to Think About the Stock Market When Earnings Guidance Becomes Meaningless -- Heard on the Street -- UPDATED -- WSJ

12.05.2025 г., 20:24 ч. UTC

Печалби

Energy Vault Holdings: Encouraging News on China/U.S. Tariff Pause, Pending Final Positive Resolution and Timing >NRGV

12.05.2025 г., 20:24 ч. UTC

Печалби

Energy Vault Holdings: No Change to Current Guidance, With Potential Rev Upside on Accelerated U.S. Battery Deliveries in 2025 >NRGV

12.05.2025 г., 20:24 ч. UTC

Топ новини

Republican Tax Plan Boosts SALT Deduction, Ends Green-Energy Breaks -- WSJ

12.05.2025 г., 20:22 ч. UTC

Придобивния, сливания и поглъщания

Spirit AeroSystems Holdings: IRS Rules That Sale to Boeing Will Qualify as a Reorganization Under Section 368(a)(1)(B)

12.05.2025 г., 20:15 ч. UTC

Печалби

Rigetti Computing Reports Earnings. How the Company Takes a Different Approach to Quantum. -- Barrons.com

12.05.2025 г., 20:10 ч. UTC

Печалби

Blink Charging 1Q Rev $20.8M >BLNK

Сравнение с други в отрасъла

Ценова промяна

Smith & Nephew PLC Прогноза

Ценова цел

By TipRanks

15.17% нагоре

12-месечна прогноза

Среден 1,231.2 GBX  15.17%

Висок 1,400 GBX

Нисък 1,025 GBX

Според 10 анализатори от Wall Street, предложили 12-месечна ценова цел за Smith & Nephew PLC през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

10 ratings

4

Купи

6

Задържане

0

Продай

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

EBITDA

Оперативна печалба

$

Относно Smith & Nephew PLC

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.